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A B S T R A C T
Background: Posttraumatic Stress Disorder (PTSD) is associated with a number of negative physical and mental
health consequences. Fear conditioning plays an important mechanistic role in PTSD, and PTSD patients also
show deficits in safety signal learning. Sleep, particularly REM sleep, is linked to improved safety learning and
extinction processes in animal models and healthy humans. No studies have examined the link between REM
sleep and safety signal learning or extinction memory in clinical populations.
Methods: This study examined the relationship between REM sleep, safety signal learning, and extinction pro-
cesses in veterans with PTSD (n=13). Patients' overnight sleep was characterized in the laboratory via poly-
somnography (PSG). The next day, participants underwent a fear conditioning paradigm during which they
acquired fear toward a visual cue. This testing session also included a visual cue that became a safety signal (CS-
). Following conditioning, the veterans' sleep was monitored overnight again, after which they underwent ex-
tinction training. Following a third night of sleep, extinction recall and safety recall were tested. Bivariate
correlations examined the relationship between the slope of safety signal learning and subsequent REM sleep, as
well as the relationship between REM sleep and subsequent extinction recall and safety recall on the last day of
testing.
Results: Veterans learned to differentiate the CS+ and the CS- on the first day of testing. Veterans who un-
derwent safety learning more quickly on the first day of testing showed more efficient REM sleep that night
(r= .607, p= .028). On the second day of testing, the patients successfully underwent extinction learning.
Patients with a higher percentage of REM sleep on the last night of the study showed more safety recall early on
the last day of testing (r= .688, p= .009).
Conclusion: To our knowledge, this was the first study to examine the relationship between objective sleep and
fear-potentiated startle performance in veterans with PTSD. Study methods were well tolerated by participants,
supporting feasibility of the experimental design. Results indicated REM sleep was associated with both initial
safety learning and subsequent safety recall. Taken together with previous studies in healthy controls, these
preliminary results provide additional evidence suggesting REM sleep could play a mechanistic role in the
maintenance of PTSD and thus identify a modifiable biological process to target in treatment of PTSD. These
findings should be replicated in larger samples.
1. Introduction
Approximately 5.2 million adults suffer from posttraumatic stress
disorder (PTSD) in the United States in a given year (Kessler et al.,
2005). PTSD is associated with a number of negative physical
(Boscarino, 2008) and mental health (Kilpatrick et al., 2003) con-
sequences. Over the past few decades, researchers have developed
evidence-based pharmacological and psychosocial interventions for
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PTSD (Foa et al., 2008). Despite these advances, not all PTSD patients
respond, or respond fully, to treatment (Schottenbauer et al., 2008).
Understanding the physiological processes involved in the development
and maintenance of PTSD symptoms will aid in understanding this
differential response to treatment. Additionally, a greater under-
standing of the mechanisms underlying treatment response will inform
the development of more effective interventions.
One example of an important mechanism in PTSD is fear con-
ditioning. Fear conditioning plays a crucial role in PTSD, as patients
with PTSD retain conditioned fear to cues associated with trauma long
after the traumatic event has passed (Milad et al., 2009; Wessa and Flor,
2007). Extinction of conditioned fear is necessary for PTSD symptom
reduction, either through the natural course of recovery or in response
to exposure-based therapies for PTSD (Foa et al., 2007). Additionally, it
is critical for patients to retain extinction over time to remain free of
PTSD symptoms long-term. A growing body of evidence also implicates
impaired safety signal learning in PTSD. Patients with PTSD are often
unable to distinguish threatening from safe environments, or have
difficulty inhibiting the fear response even in the presence of safety
signals (e.g., feeling anxious in response to hearing a helicopter even
after having returned home from combat). Laboratory studies using fear
conditioning paradigms have observed impairments in safety signal
learning in PTSD (Acheson et al., 2015; Jovanovic et al., 2012). Im-
portantly, impaired safety learning is hypothesized to contribute to
hypervigilance symptoms of PTSD (Acheson et al., 2012), and suc-
cessful safety learning is an additional mechanism in response to ex-
posure-based treatments (Foa et al., 2007).
Recent research with healthy humans shows that sleep, particularly
REM sleep, serves an important role in the acquisition and recall of
extinction memories. The importance of REM sleep to fear inhibition
learning may be critical for patients with PTSD, because some of the
most ubiquitous and distressing symptoms of PTSD are insomnia and
nightmares (Neylan et al., 1998). These sleep difficulties are associated
with disruptions in sleep architecture, particularly in REM sleep
(Germain, 2013). Previous studies using fear-potentiated startle (FPS)
paradigms in healthy human control participants link REM sleep dis-
ruption to difficulties retaining extinction over time (Straus et al.,
2017a), and other studies show associations between REM sleep con-
solidation and safety learning and retention (Marshall et al., 2014).
Together, these studies strongly suggest a likely link between REM sleep
and extinction memory and/or safety signal learning in PTSD. How-
ever, little is known about the association between sleep and extinction
and/or safety signals in clinical populations, and no studies to date have
examined the relationship between REM sleep and extinction processes
or safety signal learning in patients with PTSD. Examination of this
relationship in PTSD will demonstrate the feasibility of examining these
parameters in a PTSD sample as well as add to the literature suggesting
that sleep disturbance is a mechanism in the development and main-
tenance of PTSD.
This study examined the relationship between REM sleep, safety
signal learning, extinction, and safety recall processes in military ve-
terans with PTSD (n=13). Patients' overnight sleep was characterized
in the lab (Night 1). The next day, they underwent an FPS conditioning
session that included learning of safety signals. Following this, their
sleep was monitored overnight again (Night 2), after which they un-
derwent an extinction learning session 24 h after fear conditioning.
After a third night of sleep monitoring (Night 3), extinction recall and
safety recall were tested. Analyses examined the relationship between
safety signal learning and subsequent changes in REM sleep, as well as
the relationship between REM sleep and extinction recall. We hy-
pothesized: 1) greater safety signal learning would be associated with
less disrupted REM sleep on Night 2, 2) greater REM sleep disruption on
Night 3 would be associated with more impaired extinction recall on
the final day of testing, and 3) REM sleep on Night 3 would be asso-
ciated with better safety recall on the final day of testing. Thus, we
planned to provide preliminary evidence that sleep disruption may play
an important mechanistic role in daytime fear-related symptom severity
in PTSD patients.
2. Methods
2.1. Participants
Veterans were recruited through the VA San Diego Healthcare
System (VASDHS) to participate in the current study. The VA Internal
Review Board as well as the University of California, San Diego's
Human Research Protections Program approved all recruitment, con-
sent and testing materials for this study. Compensation was provided
for in-person eligibility screening ($10) as well as participation in the
testing phase of the study (up to $290 for completing the baseline week
and all three nights in the laboratory).
Inclusion criteria were: 1) Veteran with a primary diagnosis of
PTSD; 2) 18–50 years old; and 3) literate in English. Exclusion criteria
were: 1) A history of mania and/or psychosis; 2) substance use disorder
during the prior 6 months; 3) untreated sleep disorder other than in-
somnia and nightmares; 4) change in type and/or dosage of psycho-
tropic medication in preceding 2 months; 5) history of severe TBI (i.e.,
reported loss of consciousness for 6 h or more); 6) colorblindness; and
7) nonresponder to psychophysiological startle testing (see below).
Forty-four (44) phone screens were conducted on initial recruitment
outreach, which yielded 26 baseline assessment visits. Of these, 6
participants (23.1%) were ineligible due to being non-responders on the
startle threshold testing (see below). Five participants (19.2%) vo-
luntarily withdrew from the study prior to the sleep lab phase.
Therefore, 15 participants were enrolled and participated in at least one
in-lab sleep study. Of these, one participant was ruled out after Night 1
due to untreated Obstructive Sleep Apnea, and one additional partici-
pant withdrew after Night 2, leaving 13 participants with complete data
sets, which included 11 men and 2 women. See Table 1 for demo-
graphics of the final study sample.
2.2. Procedures
Initial screening of participants took place via telephone. Those not
excluded for obvious violations of eligibility received an in-person
screen. The in-person screening appointment included a series of
measures to confirm eligibility, including the Clinician Administered
Table 1
Demographics of the study sample.
Mean SD
Age 31.88 7.67
N %
Male 11 84.6
Female 2 15.4
Race
American Indian or Alaskan Native 0 0.0
Asian 0 0.0
Black or African American 1 7.7
Caucasian 11 84.6
Native Hawaiian or Other Pacific Islander 1 7.7
Ethnicity
Hispanic 5 38.5
Non-Hispanic 8 61.5
Military Branch
Army 4 30.8
Navy 3 23.1
Marine Corps 6 46.2
Air Force 0 0.0
Education
HS Grad 0 0.0
Some College 11 84.6
Completed Bachelor's Degree 1 7.7
Completed Master's Degree 1 7.7
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PTSD scale (CAPS) to establish current PTSD diagnosis and individual
modules from the Structured Clinical Interview for DSM-IV (SCID-IV) to
rule out exclusionary psychiatric diagnoses (see Measures below).
Informed consent was signed at the beginning of this first in-person
meeting. Participants also underwent a Startle Threshold Testing ses-
sion, which consisted of presentation of 16 acoustic startle probes (in
the absence of any visual cue) to examine baseline startle reactivity.
Veterans who did not meet the criterion of responding to at least 75%
(12 of 16) of the startle probes were deemed nonresponders and ex-
cluded from participation in the study. Those not excluded based on
these measures underwent one week of baseline sleep assessment at
home, during which they filled out Sleep Diaries and wore a wrist ac-
tigraph to characterize baseline sleep.
Testing Phase: After the baseline week, participants were brought to
the laboratory, where they spent three consecutive nights with their
sleep monitored by polysomnography. They also underwent a con-
ditioning paradigm with established reliability in the literature
(Acheson et al., 2013; Norrholm et al., 2006, 2011, 2013). See Fig. 1 for
study timeline. Participants underwent an adaptation night (Night 1) to
adjust to sleeping in the laboratory environment. This night was also
used to screen for exclusionary sleep disorders (e.g., sleep apnea). Night
1 was followed by fear/safety acquisition (described below) on Day 1.
After a second night in the laboratory (Night 2), participants underwent
extinction learning on Day 2. Participants then spent a third night of
sleep in the laboratory (Night 3), followed by extinction recall testing
on Day 3. See Fig. 2 for a diagram showing the FPS testing procedures
for each session.
Testing sessions were conducted 1 h following participants' habitual
wake time. Participants' habitual wake times ranged from 5am to 8am
and thus testing sessions ranged from 6am to 9am. For all sessions,
participants were seated in a lounge chair in a sound-attenuated room.
Visual cues were presented via LCD monitor. Sensors were fitted to
measure blink reflex, which was used as the operational measure of the
conditioned fear response, safety learning, extinction, and extinction
recall.
Fear/Safety Acquisition: During this phase, participants under-
went a fear potentiated startle (FPS) procedure to acquire conditioned
fear to a visual cue (the conditioned stimulus, or CS+; (Acheson et al.,
2013; Acheson et al., 2015; Glenn et al., 2017; Norrholm et al., 2011;
Norrholm et al., 2013; Norrholm et al., 2006). We conducted FPS ac-
quisition and extinction as previously described (Acheson et al., 2013).
In brief, the unconditioned stimulus (US) was a 500 ms puff of air de-
livered to the throat. FPS acquisition began with an acclimation period
during which 70 db of broad band background noise, followed by six
108 db, 40 ms acoustic startle probes. Following the acclimation period,
3 trial types were presented: 2 conditioned stimulus (CS) trials and one
no-stimulus trial. For each CS trial, 1 of 2 possible shapes were pre-
sented on the LCD monitor, for 6 s. Between 4 and 5 s after the onset of
the shape, a startle probe was delivered to assess fear conditioning. One
of these shapes (a blue circle, serving as CS+) was paired with an air
puff to the throat 75% of the time. The second shape (yellow circle) was
never paired with the air puff and thus served as the safety signal (CS-).
Overall, the FPS acquisition phase consisted of 24 trials, including 8
CS + trials, 8 CS- trials, and 8 Noise Alone (NA) trials during which the
startle probe was presented in the absence of any visual cue. Stimulus
presentation was block randomized with the constraint of two trials of
each type (CS+, CS−, and NA) per block. FPS was measured by eye-
blink magnitude in response to the acoustic stimuli presented in the
presence/absence of the CS+.
Extinction Learning: After spending a second night in the labora-
tory and 24 h after Fear/Safety Acquisition, participants underwent a
standard extinction procedure that consisted of 72 trials (16 CS+, 16
CS-, 16 NA). Visual cues and startle probes were presented as in the
Fear/Safety Acquisition phase, but no air puffs were delivered. The CS
+ was presented during this testing session repeatedly without the air
puff. Participants therefore had the opportunity to “un-learn” the as-
sociation between the CS+ the US (i.e., the conditioned response was
extinguished).
Extinction/Safety Recall: This phase was conducted 24 h after the
Extinction learning session, after Night 3 (see Fig. 1). It consisted of 24
Fig. 1. Timeline of testing phase.
Fig. 2. Fear Potentiated Startle Testing Procedures.
Day 1 of testing (Fear/Safety Learning) included 8
presentations of the CS+ (blue circle), paired with an
air puff to the throat 75% of the time. Day 1 also in-
cluded 8 presentations of the CS- without being paired
with the air puff, and 8 Noise Alone (NA) trials. Day 2
(Extinction Learning) included 16 presentations of the
CS+, 16 presentations of the CS-, and 16 NA trials. No
air puffs were administered during this session. Day 3
(Extinction Recall) included 8 CS+, 8 CS-, and 8 NA
trials. As on the day before, no air puffs were ad-
ministered. (For interpretation of the references to
color in this figure legend, the reader is referred to the
Web version of this article.)
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trials (8 CS+, 8 CS-, 8 NA). During this session, both the CS+ and CS-
were presented repeatedly, and no cues were paired with the air puff.
2.3. Measures
Clinician Administered PTSD Scale, DSM-5 version (CAPS-5):
The CAPS is a semistructured interview corresponding to DSM-5 criteria
for PTSD (Weathers et al., 2015). It was recently adapted to correspond
to DSM-5 symptoms of PTSD and is widely considered to be the gold
standard PTSD assessment (Weathers et al., 2001). For this study, the
CAPS was the primary method used to establish PTSD diagnosis.
Structured Clinical Interview for DSM-IV (SCID): The SCID is a
clinician-administered diagnostic interview based on DSM-IV criteria
(First et al., 2012). For this study, individual modules of the SCID were
used to rule out exclusionary Axis I disorders, including psychotic
symptoms, manic symptoms, and substance abuse/dependence during
the prior 6 months (see above).
In addition to the measures above, participants also completed
several self-report questionnaires to characterize clinical symptoms,
including the Patient Health Questionnaire, 9-item version (PHQ-9;
Kroenke et al., 2001), the PTSD Checklist, stressor-specific version
(PCL-S; Weathers et al., 1993), the Insomnia Severity Index (ISI; Batien,
Vallières and Morin, 2001), the Pittsburgh Sleep Quality Index (PSQI;
Buysse et al., 1989) and Addendum for PTSD (PSQI-A; Germain et al.,
2005). Participants also completed a standard interview regarding re-
cent medication use. When this was unclear, the PI verified this in-
formation using the patient's medical record.
2.3.1. Sleep assessments
Sleep Diaries: The sleep diary included typical subjective measures
(such as bed time, wake time, sleep latency, number and duration of
awakenings, total time in bed) and two calculated variables (total sleep
time and sleep efficiency). Frequency and intensity of nightmares were
also assessed. Daily sleep diaries are commonly used in sleep research
(Carney et al., 2012), and we have used this one in several studies.
These data were not used for investigation of the main study aims, but
instead were used to further characterize baseline sleep in this sample.
Actigraphy: Actigraphy is the most commonly used validated ob-
jective sleep assessment outside of a laboratory context (Ancoli-Israel
et al., 2003). Respironics Actiwatch 2 and Actiware software were used
to calculate total sleep time, wake after sleep onset, and sleep effi-
ciency. As with the Sleep Diaries, actigraphy data were not used for
investigation of main study aims, but were used to provide objective
estimates of participants' sleep continuity from the baseline week.
Polysomnography (PSG): During the Testing Phase of the study
(see above), participants' sleep was monitored with a standard over-
night polysomnogram, including EEG, EOG, and EMG. On Night 1,
additional monitors screened for sleep apnea and periodic leg move-
ments. Sleep recordings were scored for sleep stages (i.e. N1, N2, N3,
REM) by a single scorer and according to standardized procedures (Iber,
2007). Our three REM sleep variables (See Data Analysis below) were
determined by this scoring.
2.3.2. Psychophysiological assessments
Blink Reflex was measured during Fear/Safety Acquisition,
Extinction Learning, and Extinction Recall via two small EMG cup
electrodes (Ag/AgCl) placed below and lateral to the left eye over the
orbicularis oculi muscle, referenced to an electrode placed over the left
mastoid. EMG data were recorded at a sampling rate of 1 kHz, amplified
(0.5 mV electrode input was amplified to 2500mV signal output), band-
pass filtered (100–1000 Hz), rectified, and then smoothed with a 5-
point rolling average. EMG files were visually inspected and startle
responses were differentiated from voluntary blinks by ensuring that
onset of the startle peak occurred within 30–70ms after the startle
probe.
2.4. Analytic plan
Descriptive statistics were used to characterize demographics and
clinical symptoms (i.e., CAPS, PCL-S, PHQ-9). Descriptive statistics
were also used for the Sleep Diary, Actigraphy, and PSG to characterize
sleep.
Prior to data analysis, physiological data were scored according to
our research group's previously-established procedures (see Straus
et al., 2017a). CS+ and CS- trials were averaged within each session
into blocks of two trials each. NA trials within a session were averaged
to acquire a baseline startle response. This baseline was then subtracted
from the respective CS+ and CS- block within each session, creating
scores representing potentiated startle above baseline for each CS type
within each block. Thus, there were four blocks for the CS+ and CS-
during the acquisition session; eight blocks for the CS+ and CS- for the
extinction session; and four blocks for the CS+ and CS- during the
recall session. Participants who did not complete all components of the
testing phase of the study were dropped from final analyses.
Fear Conditioning, Safety Learning, and Extinction Data
Analysis: The Day 1 Fear/Safety Acquisition session was analyzed by
using a priori comparisons based on previous studies using the same
paradigm (e.g., Straus et al., 2017a), which served as validity checks
confirming the FPS paradigm worked as intended. Paired samples t-tests
to examine the response to the CS+ and CS- at the beginning of the
testing session (Block 1) relative to the end of the session (Block 4).
Then, paired samples t-tests were used to compare the response to the
CS + to the CS- at each block. It was hypothesized that response would
not differ by cue early in the testing session, but response to the
CS + would be greater than the CS- at the end of the session due to
participants distinguishing the threat cue versus safety cue. As in our
previous work (Straus et al., 2017a), for the extinction learning session
on Day 2, Blocks 1–2, Blocks 3–4, Blocks 5–6, and Blocks 7–8 were
averaged together to create variables representing early, early-middle,
late-middle, and late extinction learning. Then, paired samples t-tests
were used to examine response to the CS+ and CS- at the beginning of
the testing session relative to the end of the session. Finally, paired
samples t-tests were used to compare the response to the CS + to the
CS- at each of the time points (early, early-middle, late-middle, and
late). It was hypothesized that participants would distinguish the cues
early in the testing session due to the learning the previous day, but that
response to both cues would be attenuated late in the testing session
after multiple presentations of both cues without the air puff. Parallel
paired samples t-tests tests were performed to examine participants'
responses on the recall session on Day 3. It was hypothesized that
participants would not respond differently by cue at the beginning of
this session due to extinction learning the previous day.
REM Sleep and FPS Analyses: REM sleep was measured based on
three variables: 1) REM Percent (i.e., REM sleep duration divided by
total sleep duration), 2) REM Efficiency (i.e., REM minutes divided by
the total duration of all REM periods), and 3) REM Latency (i.e.,
duration of non-REM sleep before the first REM onset). These variables
were chosen a priori based on their use in previous studies (see Marshall
et al., 2014; Straus et al., 2017a).
To examine the effect of safety learning on subsequent REM sleep, a
difference score was created based on the blink response to the CS-
above baseline on Block 1 of the Acquisition session in comparison to
Block 2 (Block 1 – Block 2) to create a continuous variable representing
the speed of safety learning, with large numbers indicating rapid safety
learning. Bivariate correlation was then used to examine the relation-
ship between this score and REM latency, REM efficiency, and REM
percent on the subsequent night (Night 2).
To examine the relationship between REM sleep and extinction re-
call on the final morning of testing, an extinction recall index was
computed comparing the CS + responses above baseline at recall with
the maximal CS + responses above baseline during conditioning, based
on other studies using this paradigm (e.g., Milad et al., 2009; Acheson
L.D. Straus et al. Neurobiology of Stress 9 (2018) 22–28
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et al., 2013). The following equation was used: 100− 100(CS + re-
sponse during the first block of recall/maximum CS + block across
acquisition phase). For example, if the participant's EMG response to
the CS+ was 300 after baseline subtraction at the first block of the
extinction recall session, and reached 600 after baseline subtraction
during acquisition, the extinction retention index would be 100–100
(300/600) = 50. Bivariate correlations were then used to explore as-
sociations between this index and REM efficiency, REM percent and
REM latency on the previous night (Night 3).
To our knowledge, no previous studies have examined relationships
between REM sleep and safety recall. Therefore, we conducted some
additional exploratory analyses to investigate this in our sample. To
examine the relationship between REM sleep and safety recall on the
final morning of testing, a difference score was based on blink response
to the CS- above baseline on Block 1 of the Recall session in comparison
to Block 2 (Block 1 – Block 2). The result was a continuous variable
with large numbers indicating rapid safety recall. Bivariate correlation
was then used to examine the relationship between REM latency, REM
efficiency, and REM percent on the previous night (Night 3) and this
measure of the slope of safety recall at the subsequent Recall session.
3. Results
Clinical Symptoms: Table 2 shows a summary of clinical symptom
data. Mean total CAPS was indicative of moderately severe PTSD
symptoms (M=42.85, SD=12.22). On the PCL-S, the average score
was above the clinically significant threshold that has been suggested
for veteran populations at VA clinics (M=55.68, SD=16.29; Yeager,
Magruder, Knapp, Nicholas, Frueh, 2008). The average score on the
PHQ-9 was indicative of moderately severe depression (M=14.31,
SD=6.94).
Sleep Summary Data: Table 2 shows a summary of the sleep
measures. The average score on the ISI was suggestive of moderate
insomnia (M=14.77, SD=5.63). On the PSQI and PSQI Addendum
for PTSD, average scores were considerably above the threshold in-
dicating clinically significant sleep disturbance (PSQI: M=11.86,
SD=3.74; PSQI-A: M=10.77, SD=4.59). Sleep diaries and
actigraphy data from the baseline week showed clinically significant
insomnia symptoms, with a wide variability between participants, re-
plicating previous studies showing high variability of sleep in PTSD
patients (Straus et al., 2015). On in-lab PSG, Total Sleep Time averaged
∼6.5 h (SD=54.27min), and mean Sleep Efficiency was just under
90% (SD=6.5).
3.1. Fear conditioning and extinction testing
Fear Acquisition: Paired samples t-tests revealed participants did
not respond differently to the CS+ and the CS- during the first block
(t=0.04, p = .973), but by the last block they responded more an-
xiously to the CS + than they did to the CS- (t=2.36, p= .034),
suggesting they learned to differentiate between the “threat signal” and
the “safety signal” (Fig. 3).
Extinction Learning and Recall: Participants showed greater startle
potentiation to the CS + than they did to the CS- during early extinc-
tion learning (t=2.26, p= .042), though by late extinction learning
there was no difference in response between the two cues (t=1.24,
p = .242). Hence by the end of the testing session, participants learned
that the “dangerous” cue was now safe, and thus no longer dis-
criminated between the two cues. Discrimination remained low during
the recall test on Day 3 (CS + vs. CS- at block 1: t=1.36, p= .198 and
block 4 t= 0.57, p = .581), and CS + responding was significantly
lower than CS + responding during cue recall on Day 2. Additionally,
startle potentiation to the CS+ was significantly smaller on Block 1 of
the recall session on Day 3 in comparison to Block 1 during the ex-
tinction learning session on Day 2 (t=2.41, p= .03), supporting that
extinction recall was successful.
3.2. Safety learning, extinction, and REM sleep analyses
Safety and Fear Acquisition and Subsequent REM Sleep: There was a
significant relationship between speed of safety learning and sub-
sequent REM efficiency on Night 2 (r=0.607, p= .028). Speed of
safety learning was not significantly associated with REM latency
(r=0.168, p= .583) or REM percent on Night 2 (r=0.22, p= .474).
Bivariate correlations revealed no significant associations between
REM efficiency on Night 3 (r=0.17, p= .596), REM percent (r=0.09,
p= .793), nor REM Latency (r=−0.32, p= .318), and the extinction
retention index.
With regard to safety recall, there was a significant relationship
between REM percent on Night 3 and the slope of subsequent safety
response (r=0.69, p= .009). Neither REM latency (r=0.168,
p= .583) nor REM percent on Night 3 (r=0.22, p= .474) was asso-
ciated with the slope of safety recall.
4. Discussion
Though research in healthy humans has shown critical links be-
tween REM sleep and fear and safety learning, this was the first study to
investigate this relationship in patients with PTSD. This small pre-
liminary study (n= 13) conducted in veterans, investigated this re-
lationship using in-lab sleep assessment and a classical conditioning
FPS paradigm over a three-day period. Of note, only one participant
voluntarily withdrew from the sleep lab portion of the study, which
represents an attrition rate comparable to our previous studies in
healthy controls (Straus et al., 2017a) and supports the feasibility of
using this experimental design in patients with PTSD. Additionally,
findings from this preliminary study parallel findings in healthy human
controls. Recent studies in healthy human participants showed safety
learning is related to REM sleep (Marshall et al., 2014; Menz et al.,
2016), which then has implications for subsequently differentiating
between threat and safety. Here, we replicate that basic finding in pa-
tients with PTSD, in that worse safety learning at the acquisition session
on Day 1 was associated with less REM efficiency that night.
Table 2
Clinical characteristics of the study sample.
N % Cutoff Score
Criterion A Trauma Type
Combat 10 76.9 –
Military Sexual Trauma 2 15.4 –
Other 1 7.7 –
Mean SD
CAPS-5 42.85 12.22 25
PCL-S 55.78 16.29 50
PHQ-9 14.31 6.94 5
Insomnia Severity Index 14.77 5.63 8
PSQI Global Score 11.86 3.74 5
PSQI Addendum for PTSD 10.77 4.59 4
Sleep Diaries (baseline week)
Time in Bed (minutes) 488.56 73.82 –
Total Sleep Time (minutes) 368.47 90.89 360
Sleep Latency (minutes) 42.06 25.47 30
Wake After Sleep Onset (minutes) 77.26 53.53 30
Sleep Efficiency (%) 74.79 12.10 85
Total Number of Nightmares 8.20 7.24 –
Average Nightmare Intensity 5.15 1.92 –
Actigraphy (baseline week)
Total Sleep Time (minutes) 361.54 46.29 360
Wake After Sleep Onset (minutes) 47.07 19.54 30
Sleep Efficiency (%) 75.62 9.90 30
Polysomnography (average over 3 nights)
Total Sleep Time (minutes) 388.03 54.27 360
Sleep Latency (minutes) 17.90 18.52 30
Wake After Sleep Onset (minutes) 28.51 26.56 30
Sleep Efficiency (%) 89.85 6.20 85
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Additionally, this study showed patients with PTSD who exhibited
lower REM percent on Night 3 showed more subsequent difficulties
with safety signal recall. Together, these findings represent the first
translation of the healthy control data showing a link between safety
signals and REM sleep into a PTSD sample and further validate the
hypothesis that REM sleep disturbances may play a potential role in
maintaining daytime PTSD symptoms (Straus et al., 2017b; Germain,
2013).
The associations between safety learning and REM sleep found in
this study are understandable given the hypothesized links between
sleep and the biological processes involving fear and safety learning.
Fear conditioning involves activation of central stress responses, in-
volving the limbic system (Phillips and LeDoux, 1992) as well as the
noradrenergic system, which is, in turn, associated with disrupted REM
sleep (Raskind et al., 2007). In the current study, less efficient safety
signal learning was associated with less efficient REM sleep the fol-
lowing night, which supports the hypothesis that alterations in limbic
activity and catecholamine levels is associated with both safety learning
performance and fragmented REM sleep. In addition to activation of
limbic and noradrenergic pathways, studies have also shown inhibition
of fear, such as safety signal learning, involves activation of frontal
brain regions such as the vmPFC to serve as a “top-down” process for
modulating fear response (Jovanovic and Norrholm, 2011). Studies in
healthy control participants show sleep disruption results in increased
activation in the amygdala as well as decreased connectivity the frontal
regions needed to modulate expression of that fear response (van der
Helm et al., 2011; Nieuwenhuis and Takashima, 2011; Lerner et al.,
2017). In this study, REM sleep disruption was associated with impaired
ability to recall safety signal learning on the last day of testing. Though
we did not measure these brain systems or neurotransmitters directly in
this study, the results are in line with what would be expected given the
neurophysiological links between sleep and the fear system
(Spoormaker et al., 2010, 2012; Lerner et al., 2017). Direct causality
cannot be confirmed due to the small study sample and associational
design; however, these data support the notion sleep disruption could
play a critical role in the development and/or maintenance of daytime
PTSD symptoms.
Contrary to other studies in PTSD samples, participants in our study
did not show deficits in extinction recall. Also, contrary to our hy-
potheses, no relationship was found between REM sleep consolidation
and reactivity to the threat signal (CS+), either during the extinction
learning session or during the extinction recall session the following
day. Many studies show extinction recall deficits in PTSD compared to
controls (e.g., Milad et al., 2008), and other prior work in animals (e.g.,
Fu et al., 2007; Datta & O'Malley, 2013) and healthy human control
participants (Straus et al., 2017a; Spoormaker et al, 2010, 2012) have
shown fragmentation of REM sleep is associated with impaired recall of
extinguished fear. These results were not duplicated in this study. There
are a variety of possible explanations for these null results. Notably, this
study did not compare PTSD patients to control participants, which
limits the interpretation of normative versus impaired extinction pro-
cesses. Additionally, studies in animals or healthy human control par-
ticipants often directly manipulate sleep by use of total sleep depriva-
tion (Straus et al., 2017a), or selective REM sleep deprivation
(Spoormaker et al., 2012) and compare findings to a control group who
did not undergo the sleep manipulation. This type of design allows for
the ability to determine the causal effects of sleep disruption on fear
and extinction parameters. This study did not directly manipulate REM
sleep. Future studies could use a manipulation to either disrupt REM
sleep (e.g., via REM deprivation) or consolidate REM sleep overnight
(e.g., via administration of a pharmacological agent such as prazosin),
and examine the relationship between REM sleep and extinction pro-
cesses in PTSD patients. Perhaps the most important consideration for
these null results, though, is the small size of this study. The question
about the relationship between REM sleep and extinction processes in
PTSD patients remains open. Larger studies may be needed to detect
these relationships.
Though this study establishes important links between REM sleep
disturbance and safety learning processes in patients with PTSD, there
are a few limitations worth noting. First, this was a small exploratory
study. Some analyses were planned and based on previous literature,
while others were exploratory and meant to inform future studies. The
small size and exploratory nature of this study resulted in limited power
to examine relationships between sleep and daytime fear learning. This
study did not find hypothesized links between REM sleep and extinction
processes. As noted above, the small size of this study results in a lack of
statistical power to detect effects. Future research should scale up and
re-examine potential relationships between REM sleep and fear/ex-
tinction parameters. Second, this study only examined behavioral re-
sponses. Future studies should include neuroimaging or other biological
sampling to examine hypothesized links between fear learning, neural
networks, and neurotransmitters. Third, due to recruitment concerns
and limitations regarding statistical power in this small sample, we did
not comprehensively control for psychotropic use, psychiatric co-
morbidities (e.g., depression, panic symptoms), or medical comorbid-
ities that may have affected sleep continuity during the in-lab portion of
this study or performance during startle testing. Future studies could
limit participation to medication-free, medically healthy participants,
or control for medication use, psychiatric symptoms, and medical co-
morbidities for a more “pure” test of study hypotheses (although one
should note that would also reduce generalizability of the findings).
Despite these limitations, this study represents the first published study
to examine the link between REM sleep and fear inhibition in patients
with PTSD. Results extend previous research and add to the literature
Fig. 3. EMG startle potentiation compared to baseline, by testing session and stimulus type. Data points represent difference scores of the EMG startle response to the
CS + or CS- with the average EMG response to Noise Alone trials subtracted out. Fear/Safety Learning took place on Day 1, Extinction Learning took place on Day 2,
and Extinction Recall took place on Day 3.
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suggesting sleep disturbance interferes with safety learning, under-
scoring the argument sleep disruption is an important factor in the
development and maintenance of daytime PTSD symptoms.
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